Reuters logo
BRIEF-GlycoMimetics qtrly loss per share $‍0.24
November 8, 2017 / 12:48 PM / in 10 days

BRIEF-GlycoMimetics qtrly loss per share $‍0.24

Nov 8 (Reuters) - Glycomimetics Inc

* Glycomimetics reports program updates and third quarter 2017 results

* Glycomimetics inc - ‍phase 3 clinical trial of rivipansel on track for completion in second half of 2018​

* Glycomimetics inc qtrly loss per share $‍0.24​

* Glycomimetics inc - ‍research and development expenses decreased slightly to $5.8 million for quarter ended september 30, 2017 as compared to $5.9 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below